Green Lifescience Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	40,340	24,861	22,369	36,505	25,338
Other Revenue	-0	-	0	0	0
Revenue	40,340	24,861	22,369	36,505	25,338
Revenue Growth (YoY)	62.26%	11.14%	-38.72%	44.07%	3.16%
Cost of Revenue	37,872	21,881	24,683	37,861	27,608
Gross Profit	2,467	2,980	-2,313	-1,356	-2,270
Selling, General & Admin	1,909	1,685	1,996	2,027	2,085
Research & Development	292.17	734.99	112.11	425.82	109.59
Other Operating Expenses	1.54	11.75	3.08	7.57	0.53
Operating Expenses	2,263	2,603	2,330	2,602	2,378
Operating Income	204.29	376.91	-4,643	-3,958	-4,648
Interest Expense	-242.17	-238.06	-240.43	-113.34	-22.2
Interest & Investment Income	390.02	453.73	697.58	626.6	674.92
Currency Exchange Gain (Loss)	11.24	988.53	-55.15	-5.29	-18.17
Other Non Operating Income (Expenses)	-44.58	125.65	-65.72	-106.51	181.34
EBT Excluding Unusual Items	318.81	1,707	-4,307	-3,557	-3,832
Gain (Loss) on Sale of Investments	1,148	-144.81	43.71	694.8	416.74
Gain (Loss) on Sale of Assets	-0	-	-	1.39	-2.24
Asset Writedown	-1,357	-	-12,095	-	-
Pretax Income	110.13	1,562	-16,358	-2,860	-3,418
Income Tax Expense	-	-	-	665.17	-282.01
Net Income	110.13	1,562	-16,358	-3,526	-3,136
Net Income to Common	110.13	1,562	-16,358	-3,526	-3,136
Net Income Growth	-92.95%	-	-	-	-
Shares Outstanding (Basic)	-	19	20	20	20
Shares Outstanding (Diluted)	-	19	20	20	20
Shares Change (YoY)	-	-3.61%	-0.19%	-	-
EPS (Basic)	-	81.18	-819.47	-176.28	-156.79
EPS (Diluted)	-	81.18	-819.47	-176.28	-156.79
Free Cash Flow	-495.66	-255.13	-125.67	-6,030	-2,832
Free Cash Flow Per Share	-	-13.26	-6.30	-301.49	-141.61
Gross Margin	6.12%	11.98%	-10.34%	-3.72%	-8.96%
Operating Margin	0.51%	1.52%	-20.76%	-10.84%	-18.34%
Profit Margin	0.27%	6.28%	-73.13%	-9.66%	-12.38%
Free Cash Flow Margin	-1.23%	-1.03%	-0.56%	-16.52%	-11.18%
EBITDA	994.17	1,145	-2,167	-1,189	-2,083
EBITDA Margin	2.46%	4.61%	-9.69%	-3.26%	-8.22%
D&A For EBITDA	789.88	768.54	2,476	2,769	2,565
EBIT	204.29	376.91	-4,643	-3,958	-4,648
EBIT Margin	0.51%	1.52%	-20.76%	-10.84%	-18.34%
Advertising Expenses	-	-	2	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.